Form 8-K X4 Pharmaceuticals, Inc For: Aug 22
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
X4 Pharmaceuticals directors resign, board appointments made
August 25, 2025 8:16 AM EDTX4 Pharmaceuticals Inc. (NASDAQ: XFOR) announced that two directors resigned from its board effective immediately on August 22, 2025.
David McGirr and R. Keith Woods stepped down from the board of directors and all committees. The company stated the resignations were not due to any disagreement... More
